| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34508863_HAS_TOPIC_C0003250> <https://research.tib.eu/covid-19/entity/34508863_HAS_TOPIC_C0019993> <https://research.tib.eu/covid-19/entity/34508863_HAS_TOPIC_C0041703> <https://research.tib.eu/covid-19/entity/34508863_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34508863_HAS_TOPIC_C0235874> <https://research.tib.eu/covid-19/entity/34508863_HAS_TOPIC_C0242656> <https://research.tib.eu/covid-19/entity/34508863_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34508863_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34508863_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Clinical Operations group, HCA Healthcare, Nashville, TN 37023, United States.\', \'Clinical Operations group, HCA Healthcare, Nashville, TN 37023, United States. Electronic address: Jeffrey.guy@hcahealthcare.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Elders_Ty> <https://research.tib.eu/covid-19/entity/Goldin_Laurel> <https://research.tib.eu/covid-19/entity/Guy_Jeffrey> <https://research.tib.eu/covid-19/entity/Korwek_Kimberly> <https://research.tib.eu/covid-19/entity/Poland_Russell> <https://research.tib.eu/covid-19/entity/Werhane_Leslie>
?:doi	S1201-9712(21)00713-X10.1016/j.ijid.2021.09.007
?:doi	<https://research.tib.eu/covid-19/entity/S1201-9712%2821%2900713-X10.1016/j.ijid.2021.09.007>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34508863>
?:pmid	<https://research.tib.eu/covid-19/entity/34508863>
?:pmid	34508863
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0003250_ADMINISTERED_TO_C0030705> <https://research.tib.eu/covid-19/entity/C0013227_ADMINISTERED_TO_C0030705>
?:title	Reactions and COVID-19 disease progression following SARS-CoV-2 monoclonal antibody infusion.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34508863>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34508863>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all